Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
L.R. Tomasoni, A. Patroni, C. Torti, G. Paraninfo, F. Gargiulo, E. Quiros-Roldan, M.C. Uccelli, P. Airò, C. Tinelli, G. Carosi & F. Castelli. (2003) Predictors of Long-Term Immunological Outcome in Rebounding Patients on Protease Inhibitor-Based HAART After Initial Successful Virologic Suppression: Implications for Timing to Switch. HIV Clinical Trials 4:5, pages 311-323.
Read now
Read now
Andrea Patroni, Carlo Torti, Lina Tomasoni, Eugenia Quiros Roldan, Davide Bertelli,Massimo Puoti, Gian Pietro Cadeo, Intissar Sleiman, Carmine Tinelli, Giampiero Carosi & Francesco Castelli. (2002) Effect of Highly Active Antiretroviral Therapy (HAART) and Hepatitis C Co-Infection on Hyperlipidemia in HIV-Infected Patients: A Retrospective Longitudinal Study. HIV Clinical Trials 3:6, pages 451-461.
Read now
Read now
Patroni Andrea, Torti Carlo, Tomasoni Lina, Quiros Roldan Eugenia, Bertelli, Davide, Puoti Massimo, Cadeo Gian Pietro, Sleiman Intissar, Tinelli Carmine, Carosi Giampiero & Castelli Francesco. (2002) Effect of Highly Active Antiretroviral Therapy (HAART) and Hepatitis C Co-Infection on Hyperlipidemia in HIV-Infected Patients: A Retrospective Longitudinal Study. HIV Clinical Trials 3:6, pages 451-461.
Read now
Read now
Articles from other publishers (5)
Carlo Torti, Elena Raffetti, Francesco Donato, Francesco Castelli, Franco Maggiolo, Gioacchino Angarano, Francesco Mazzotta, Andrea Gori, Laura Sighinolfi, Angelo Pan, Roberto Cauda, Alfredo Scalzini, Eugenia Quiros-Roldan, Paola Nasta, Giampietro Gregis, Simone Benatti, Simona Digiambenedetto, Nicoletta Ladisa, Mariarosaria Giralda, Annalisa Saracino, Filippo Castelnuovo, Massimo Di Pietro, Sergio Lo Caputo, Giuseppe Lapadula, Silvia Costarelli, Silvia Lorenzotti, Nicola Mazzini, Giuseppe Paraninfo, Salvatore Casari, Emanuele Focà, Chiara Pezzoli, Massimiliano Fabbiani, Laura Monno, Piera Pierotti, Claudio Ble, Sebastiano Leone, Maria Concetta Postorino, Chiara Fornabaio, Fabio Zacchi, Alessia Zoncada & Giampiero Carosi. (2015) Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). International Journal of Epidemiology, pages dyv192.
Crossref
Crossref
M.C. Postorino, M. Prosperi, E. Quiros-Roldan, F. Maggiolo, S. Di Giambenedetto, A. Saracino, S. Costarelli, S. Lorenzotti, L. Sighinolfi, M. Di Pietro & C. Torti. (2015) Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort. Clinical Microbiology and Infection 21:4, pages 386.e1-386.e9.
Crossref
Crossref
Carlo Torti, Franco Maggiolo, Andrea Patroni, Fredy Suter, Nicoletta Ladisa, Giuseppe Paraninfo, Piera Pierotti, Anna Maria Orani, Lorenzo Minoli, Claudio Arici, Laura Sighinolfi, Carmine Tinelli & Giampiero Carosi. (2005) Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort. Journal of Antimicrobial Chemotherapy 56:1, pages 190-195.
Crossref
Crossref
Bruno Ledergerber. (2004) Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. The Lancet 364:9428, pages 51-62.
Crossref
Crossref
Peter J. Ruane, Marshall K. Kubota, Arthur L. Williams, Julio C. Arroyo, Albert Canas, Gary J. Richmond, Cathy Alsop, Linda Yau, Siegrid M. Hessenthaler & Jaime E. Hernandez. (2004) Safety/Tolerability and Efficacy of Abacavir-Containing Combination Therapy in HIV-1-Infected Adults in a Clinical Practice Setting: Results of ZORRO. Infectious Diseases in Clinical Practice 12:1, pages 15-25.
Crossref
Crossref